Introduction:

Healthcare data plays an important role in the innovation and improvement of clinical pharmacy (CP) service. In our setting, interventions performed by clinical pharmacists serve as a unique tool to identify stakeholder needs, assess current performance and identify gaps through quality improvement projects (QIPs).

Objectives:

To describe the utilization of CP intervention data in deriving QIPs to optimize CP services towards patient-centered activities.

Material and Methods:

This retrospective observational study analyzed a total of 17,644 documented CP interventions of a tertiary private hospital, between January 2014 and December 2018. Analyzed interventions focused on three most common categories, namely Adverse Event Prevented (AEP), Medication Reconciliation (MR) and Patient Education (PE). QIPs were derived and implemented following the yearly analysis, including: 1) conducted multiple training on safe drug administration topics to nursing and pharmacy staff; 2) issuance of various in-house references for nursing and pharmacy staff; 3) published several patient education materials; and 4) implementation of numerous MR-related initiatives.

Results:

Following QIPs implementation, AEP interventions showed a decreasing trend from 20% (2014) to 13% (2018), and MR and PE interventions increased from 12% (2014) to 47% (2018) and 14% (2014) to 28% (2017) respectively.

Conclusion:

Systematic data collection and analysis of clinical pharmacists' interventions along with implementation of QIPs have improved processes and minimized the opportunities for error and adverse events. This enabled clinical pharmacists to allocate more time on patient-centered activities, particularly in MR and PE, facilitating a paradigm shift in the institution towards patient-centered health outcomes.